贵州三力: 贵州三力制药股份有限公司关于部分董事兼高级管理人员减持计划实施完毕暨减持结果公告

Summary of Key Points Core Viewpoint - The announcement details the completion of a share reduction plan by Zhang Qianfan, the Vice Chairman and General Manager of Guizhou Sanli Pharmaceutical Co., Ltd, who reduced his holdings in the company through a concentrated bidding process. Group 1: Shareholding Information - Before the reduction plan, Zhang Qianfan held 714,600 shares, representing 0.1744% of the company's total share capital [1] - The reduction plan was initially disclosed on June 12, 2025, with a maximum planned reduction of 178,650 shares, which is 0.0436% of the total share capital [1][2] Group 2: Reduction Implementation Results - As of July 7, 2025, Zhang Qianfan successfully reduced his holdings by 178,650 shares through concentrated bidding, achieving the planned reduction [2][3] - The shares were sold within a price range of 11.85 to 11.95 yuan per share, totaling approximately 2,122,303.23 yuan [2] - After the reduction, Zhang Qianfan's remaining shares amount to 535,950, which is 0.1308% of the total share capital [2]